Investors are betting that Lilly will maintain its momentum. Its share price has climbed by a third since the start of 2024; ...

The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...

The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare should cover them.

Donald Trump, at 78, is aggressively pursuing his second term, marked by significant policy changes and a noticeable physical ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Novo Nordisk partners with telehealth ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

UB researcher Nicole Albanese talks about recent developments, including the end of the shortage of weight-loss drugs and the ...

U.S. drug distributor Cencora raised its annual profit forecast on Wednesday, driven by robust demand for costly specialty medicines and weight-loss drugs.

Weight-loss medications such as Ozempic, Wegovy, and Mounjaro have attracted widespread attention, making headlines across ...

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related ...

Health and Human Services Secretary Robert F. Kennedy Jr. spoke with CBS News in an exclusive interview. Here are some ...